Advanced search
Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 33, 2021 - Issue 6
Submit an article Journal homepage
561
Views
0
CrossRef citations to date
0
Altmetric
Articles

PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia

Casey D. Xavier Halla Institute for Sexual and Gender Minority Health and Wellbeing, Northwestern University, Chicago, IL, USA;b Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1658-3717View further author information
ORCID Icon,
Justin C. Smithc Department of Behavioral, Social, & Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, USA;d Positive Impact Health Centers, Atlanta, GA, USAView further author information
,
Robert A. DriggersView further author information
,
Bethany Stollere Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USAView further author information
,
Zara Khane Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USAORCID Iconhttps://orcid.org/0000-0002-7624-6379View further author information
ORCID Icon,
Jingjing Lic Department of Behavioral, Social, & Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, USAORCID Iconhttps://orcid.org/0000-0003-4652-3379View further author information
ORCID Icon,
Elisa H. Ignatiusf Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USAView further author information
&
Aaron J. Sieglerc Department of Behavioral, Social, & Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, USA;e Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USAView further author information
 show all
Pages 706-711 | Received 09 Oct 2019, Accepted 11 Aug 2020, Published online: 24 Aug 2020

References

  • Bauermeister, J. A., Meanley, S., Pingel, E., Soler, J. H., & Harper, G. W. (2013). PrEP awareness and perceived barriers among single young men who have sex with men in the United States. Current HIV Research, 11(7), 520. https://doi.org/10.2174/1570162.
  • Berwick, D. M. (2003). Disseminating innovations in health care. JAMA, 289(15), 1969–1975. https://doi.org/10.1001/jama.289.15.1969.
  • Centers for Disease Control and Prevention. (2017). HIV Surveillance Report, 2016 http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.
  • Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation science, 4(1), 50. https://doi.org/10.1186/1748-5908-4-50
  • Grulich, A. E., Guy, R., Amin, J., Jin, F., Selvey, C., Holden, J., Schmidt, H.-M. A., Zablotska, I., Price, K., Whittaker, B., Chant, K., Cooper, C., McGill, S., Telfer, B., Yeung, B., Levitt, G., Ogilvie, E. E., Dharan, N. J., Hammoud, M. A., … Parkhill, N. (2018). Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: The EPIC-NSW prospective cohort study. The lancet HIV, 5(11), e629–e637. https://doi.org/10.1016/S2352-3018(18)30215-7
  • Kuhns, L. M., Hotton, A. L., Schneider, J., Garofalo, R., & Fujimoto, K. (2017). Use of pre-exposure prophylaxis (PrEP) in young men who have sex with men is associated with race, sexual risk behavior and peer network size. AIDS and Behavior, 21(5), 1376–1382. https://doi.org/10.1007/s10461-017-1739-0
  • Landovitz, R., Grinszteijn, B., Dawood, H., Liu, A., Magnus, M., Hosseinipour, M., Panchia, R., Cottle, L., Chau, G., Richardson, P., Marzinke, M., Hendrix, C., Tolley, B., Adeyeye, A., Burns, D., Rinehart, A., Margolis, D., McCauley, M.B., & Eron, J. (2017, July 23-26). Safety, tolerability and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected women and men: HPTN 077. IAS 207 Conference on HIV Pathogenesis Treatment and Prevention, Paris, France.
  • Landovitz, R., Donnell, D., Clement, M., Hanscom, B., Cottle, L., Coelho, L., Cabello, R., Chariyalestak, S., Dunne, E., Frank, I., Gallardo, J., Gaur, A., Gonzalez, P, Ha, V., Hinojosa, J., Kallas, E., Kelley, C., Losso, M., Valdez Madruga, J, & Grinsztejn, B. , for the HPTN 083 Study Team. (2020, July 6-10). HPTN 083 interim results: Pre-exposure prophylaxis containing long-acting injectable cabotegravir is safe and highly effective for cisgender men and transgender women who have sex with men. The 23rd International AIDS Conference (AIDS 2020: Virtual).
  • Markowitz, M., Frank, I., Grant, R. M., Mayer, K. H., Elion, R., Goldstein, D., Fisher, C., Sobieszczyk, M. E., Gallant, J. E., Van Tieu, H., Weinberg, W., Margolis, D. A., Hudson, K. J., Stancil, B. S., Ford, S. L., Patel, P., Gould, E., Rinehart, A. R., Smith, K. Y., & Spreen, W. R. (2017). Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): A multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. Lancet HIV, 4(8), e331–e340. https://doi.org/10.1016/S2352-3018(17)30068-1
  • Muessig, K. E., Nekkanti, M., Bauermeister, J., Bull, S., & Hightow-Weidman, L. B. (2015). A systematic review of recent smartphone, Internet and Web 2.0 interventions to address the HIV continuum of care. Current HIV/AIDS Reports, 12(1), 173–190. https://doi.org/10.1007/s11904-014-0239-3
  • Murray, M. I., Markowitz, M., Frank, I., Grant, R. M., Mayer, K. H., Hudson, K. J., Stancil, B. S., Ford, S. L., Patel, P., Rinehart, A. R., Spreen, W. R., & Margolis, D. A. (2018). Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial. HIV Clinical Trials, 19(4), 129–138. https://doi.org/10.1080/15284336.2018.1511346
  • Sanchez, T. H., Sullivan, P. S., Rothman, R. E., Brown, E. H., Fitzpatrick, L. K., Wood, A. F., Hernandez, P. I., Nunn, A. S., Serota, M. L., & Moreno-Walton, L. (2014). A novel approach to realizing routine HIV screening and enhancing linkage to care in the United States: Protocol of the FOCUS program and early results. JMIR research protocols, 3(3), e39. https://doi.org/10.2196/resprot.3378
  • Siegler, A. J., Mouhanna, F., Giler, R. M., Weiss, K., Pembleton, E., Guest, J., Jones, J., Castel, A., Yeung, H., Kramer, M., McCallister, S., & Sullivan, P. S. (2018). The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States. Annals of Epidemiology, 28(12), 841–849. https://doi.org/10.1016/j.annepidem.2018.06.005
  • Sullivan, P. S., Mena, L., Elopre, L., & Siegler, A. J. (2019). Implementation Strategies to Increase PrEP Uptake in the South. Curr HIV/AIDS Rep, https://doi.org/10.1007/s11904-019-00447-4
  • UNAIDS. (2018). Fact Sheet - July 2018. Retrieved 10 October 2018 from http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
  • VERBI Software. (2016). MAXQDA Analytics Pro [Computer Programme]. VERBI.
  • Vu, K., Rafie, S., Grindlay, K., Gutierrez, H., & Grossman, D. (2019). Pharmacist intentions to prescribe hormonal contraception following new legislative authority in California. Journal of pharmacy practice, 32(1), 54–61. https://doi.org/10.1177/0897190017737897.
  • Wehby, G. L., & Lyu, W. (2018). The impact of the ACA Medicaid expansions on health insurance coverage through 2015 and coverage disparities by age, race/ethnicity, and gender. Health Services Research, 53(2), 1248–1271. https://doi.org/10.1111/1475-6773.12711.
  • World Health Organization (WHO). (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. https://apps.who.int/iris/bitstream/handle/10665/186275/9789241509565_eng.pdf.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.